Skip to Main Content

Paper Details

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
2
2023
Author NameAffiliation
Nicholas van AsThe Royal Marsden NHS Foundation Trust
Charles SwantonThe Francis Crick Institute, UK University College London Cancer Institute
  • 1 - 2

Datasets

Release 1.2